PTAB challenges

Based on the single Patent Trial and Appeal Board (PTAB) proceeding filed against US patent 11,841,803, here is a complete analysis of what happened and its strategic implications.

Proceedings overview

One IPR has been filed against this patent, and the Board declined to institute the trial. This means all claims of US patent 11,841,803 have survived their only PTAB challenge to date, slightly strengthening the patent's defensive posture as it rebuffed an attempt by a major competitor to invalidate it.

IPR2026-00011 — NVIDIA Corporation v. Onesta IP, LLC

• Type: Inter Partes Review (IPR)
• Filed: 2025-10-15
• Status: Discretionary Denial — The PTAB declined to review the patent's validity, so a trial on the merits of the invalidity arguments never occurred.
• Judge panel: Because the proceeding was denied at institution, the full record including the assigned panel may not be readily public. However, decisions at this stage are typically made by a panel of three Administrative Patent Judges.
• Petition grounds: The petition reportedly challenged an unknown subset of claims under 35 U.S.C. § 103 (obviousness) based on prior art references. The specific claims and art are not detailed in the available high-level data.
• Institution decision: The PTAB denied institution on 2026-03-13. This was not a ruling that the patent claims were valid over the cited prior art. Instead, it was a "discretionary denial," likely exercised under 35 U.S.C. § 314(a). Such denials often occur when there is a co-pending district court or ITC litigation involving the same patent that is nearing a final resolution, making the parallel PTAB proceeding inefficient in the Board's view (under the Apple Inc. v. Fintiv, Inc. framework).
• Final Written Decision: None issued, as the trial was not instituted.
• Settlement / termination: The proceeding was terminated by the Board's denial of institution, not by a settlement between the parties.
• Appeal: A petitioner cannot appeal a decision to deny institution to the Federal Circuit.
• Defensive value: This proceeding provides minimal defensive value for a party other than NVIDIA. Because the Board did not consider the merits of the invalidity arguments, the prior art asserted by NVIDIA remains available for use in a future IPR or in district court litigation. However, the patent owner, Onesta IP, can point to this denial as evidence that the patent has withstood a validity challenge from a sophisticated party.

Strategic summary

All claims of US patent 11,841,803 remain valid and enforceable. The denial of institution in IPR2026-00011 was a procedural victory for the patent owner, not a substantive one on the merits of the patent's validity.

• Claim Status: All claims of US patent 11,841,803 (claims 1-20) are UNTESTED on the merits at the PTAB. No claims have been canceled or sustained in a Final Written Decision.
• Estoppel Landscape: Because the IPR was not instituted, statutory estoppel under 35 U.S.C. § 315(e) does not apply. The petitioner, NVIDIA, is free to raise the same invalidity grounds, or any other grounds, in a district court or ITC proceeding. A different potential defendant is completely unencumbered by this proceeding and can use any available prior art in a future validity challenge.
• Pattern Signals: The patent was originally assigned to a major operating company (Advanced Micro Devices, Inc.) and was later transferred to an enforcement entity (Onesta IP, LLC) in late 2024. The IPR was filed by a direct competitor (NVIDIA Corporation), suggesting this patent is being actively asserted in the GPU market. The discretionary denial indicates that the patent owner is likely pursuing its enforcement campaign aggressively in federal court or the ITC, which has progressed to a point that the PTAB deemed a parallel IPR duplicative.

Recommended next steps

For a defendant currently facing an assertion of US patent 11,841,803, the key takeaway is that the patent remains fully intact.

• The denial of institution in IPR2026-00011 means a PTAB challenge is not a guaranteed path to invalidating this patent, particularly if there is ongoing, fast-moving litigation. The patent owner has already successfully argued for a discretionary denial once.
• Any defensive strategy must assume all 20 claims are valid and must be prepared to litigate validity in district court or the ITC without the benefit of a parallel IPR.
• The absence of any other PTAB activity is notable. While the patent survived one challenge procedurally, it has not yet faced a full merits review at the PTAB, meaning its claims cannot be considered "hardened" by withstanding a substantive IPR trial. A new defendant could still consider filing an IPR, but would need a strategy to overcome potential Fintiv arguments.